FDA opens door to flavored vapes, alarming anti-smoking advocates
Public-health groups warn the move could reignite youth vaping after years of declines in teen e-cigarette use
James R. Hood
‘Low T’ boom raises concerns over overdiagnosis, aggressive marketing to men
Testosterone prescriptions are surging as private clinics, influencers and social media campaigns promote “low T” as a hidden cause of fatigue, weight gain and low libido
Five squeezes, one wallet: The pressures hitting U.S. consumers this week
American consumers are walking into the second week of May juggling a tighter set of trade-offs than at any point this year.
Court ruling could force IRS to refund pandemic-era late fees to millions
The case is still in court but taxpayers should file a protective refund request now
GM to pay $12.75m to settle California claims it sold drivers’ location data to brokers
The company sold data it collected through its OnStar service
Delays in EpiPen Use Drive Fatal Anaphylaxis in Children, New Studies Find
Having a prescription isn't enough. Patients need to have the EpiPen with them.
Lawsuits against GLP-1 drugmakers surge over alleged failure to warn about serious side effects
Thousands of lawsuits have been filed against makers of blockbuster GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound